Suraj Ashok Muley

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi Autoimmune rippling muscle
    Suraj Ashok Muley
    Department of Neurology, University of Minnesota, Minneapolis, USA
    Neurology 61:869-70. 2003
  2. ncbi Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids
    Suraj Ashok Muley
    Department of Neurology, University of Minnesota, Minneapolis, MN 55455, USA
    Arch Neurol 65:1460-4. 2008
  3. ncbi Inflammatory demyelinating neuropathies
    Suraj Ashok Muley
    Suraj Ashok Muley, MD Department of Neurology, University of Minnesota, Minneapolis, MN 55455, USA
    Curr Treat Options Neurol 11:221-7. 2009
  4. ncbi Multifocal motor neuropathy
    Suraj Ashok Muley
    Barrow Neurological Institute, Department of Neurology, Phoenix, AZ 85013, USA
    J Clin Neurosci 19:1201-9. 2012

Collaborators

Detail Information

Publications4

  1. ncbi Autoimmune rippling muscle
    Suraj Ashok Muley
    Department of Neurology, University of Minnesota, Minneapolis, USA
    Neurology 61:869-70. 2003
  2. ncbi Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids
    Suraj Ashok Muley
    Department of Neurology, University of Minnesota, Minneapolis, MN 55455, USA
    Arch Neurol 65:1460-4. 2008
    ..Pulsed steroids have nongenomic actions not seen with low-dose steroids, including rapid inhibition of arachidonic acid release and of calcium and sodium cycling across plasma membranes of immune cells...
  3. ncbi Inflammatory demyelinating neuropathies
    Suraj Ashok Muley
    Suraj Ashok Muley, MD Department of Neurology, University of Minnesota, Minneapolis, MN 55455, USA
    Curr Treat Options Neurol 11:221-7. 2009
    ..Treatment is generally started with prednisone, IVIg, or plasma exchange. Rituximab and cyclophosphamide are used only in progressive, treatment-resistant disease because of the potential for serious adverse effects...
  4. ncbi Multifocal motor neuropathy
    Suraj Ashok Muley
    Barrow Neurological Institute, Department of Neurology, Phoenix, AZ 85013, USA
    J Clin Neurosci 19:1201-9. 2012
    ..Anti-GM1 antibodies can be found in some patients but it is unclear whether these antibodies are pathogenic. Intravenous immunoglobulin is the mainstay of treatment but other immunosuppressive treatments can also be effective...